Zemaira Eosinophilic Esophagitis Pilot Study
NCT05485155
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Eosinophilic Esophagitis
Interventions
DRUG:
Alpha-proteinase inhibitor
Sponsor
Children's Hospital Medical Center, Cincinnati
Collaborators
[object Object]
[object Object]